M&A Deal Summary

Emmes Acquires VaxTrials

On October 5, 2023, Emmes acquired life science company VaxTrials

Acquisition Highlights
  • This is Emmes’ 5th transaction in the Life Science sector.
  • This is Emmes’ 1st transaction in Panama.

M&A Deal Summary

Date 2023-10-05
Target VaxTrials
Sector Life Science
Buyer(s) Emmes
Deal Type Add-on Acquisition

Target

VaxTrials

Panama City, Panama
VaxTRIALS is a specialized clinical research organization that provides innovative solutions for managing and monitoring vaccine clinical trial activities across Latin America. The company has built a reputation for helping clients, sponsors and vendors achieve extraordinary results in the implementation of their studies. VaxTRIALS was formed in 2012 and is based in Panama City, Panama.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Emmes

Rockville, Maryland, United States

Category Company
Founded 1977
Sector Life Science
Employees600
DESCRIPTION

Emmes is a global, tech-enabled full-service clinical research organization (CRO) platform dedicated to supporting the advancement of public health and biopharmaceutical innovation. Emmes was founded in 1977 and is based in Rockville, Maryland.


DEAL STATS #
Overall 7 of 7
Sector: Life Science M&A 5 of 5
Type: Add-on Acquisition M&A Deals 7 of 7
Country: Panama M&A 1 of 1
Year: 2023 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-03-21 Essex Management

Rockville, Maryland, United States

Essex Management provides bioinformatics and health information technology (HIT) consulting services to government, private sector and academic organizations. Essex Management was founded in 2009 and is based in Rockville, Maryland.

Buy -